Forodesine Hydrochloride

CHEMBL550755 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
302.7 g/mol
LogP
Phase
4

A hydrochloride salt form of forodesine, a purine nucleoside phosphorylase inhibitor investigated for treating T-cell malignancies including leukemia and lymphoma. The hydrochloride salt improves the compound's solubility and bioavailability for clinical use. It acts selectively on lymphoid cells, potentially sparing other tissues.

الوزن الجزيئي

302,7100 g/mol

TPSA

130,00 Ų

المجالات العلاجية

آلية العمل

Functions as a nucleoside analog that is incorporated into viral or cellular DNA/RNA during replication, causing chain termination or coding errors that inhibit pathogen proliferation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Functions as a nucleoside analog that is incorporated into viral or cellular DNA/RNA during replication, causing chain termination or coding errors that inhibit pathogen proliferation.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12

InChI

InChI=1S/C11H14N4O4.ClH/c16-2-5-9(17)10(18)7(15-5)4-1-12-8-6(4)13-3-14-11(8)19;/h1,3,5,7,9-10,12,15-18H,2H2,(H,13,14,19);1H/t5-,7+,9-,10+;/m1./s1

Molecular Formula

C11H15ClN4O4

HBD / HBA

7 / 6

الروابط القابلة للدوران

2

الذرات الثقيلة

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A hydrochloride salt form of forodesine, a purine nucleoside phosphorylase inhibitor investigated for treating T-cell malignancies including leukemia and lymphoma. The hydrochloride salt improves the compound's solubility and bioavailability for clinical use. It acts selectively on lymphoid cells, potentially sparing other tissues.

Functions as a nucleoside analog that is incorporated into viral or cellular DNA/RNA during replication, causing chain termination or coding errors that inhibit pathogen proliferation.

Yes, Forodesine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL550755. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 135449327. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.